Docket #: S98-083
Beta 1 Adrenergic Receptor Gene Disruption Mouse (Beta1 ARGDM)
Adrenergic receptors are plasma membrane proteins that mediate cellular responses to the hormone/neurotransmitters adrenaline and nonadrenaline which are released from sympathetic nerve terminals or the adrenal gland. The three closely related subtypes of beta adrenergic receptors (beta 1, 2 and 3) are found in humans and mice. These receptors mediate a wide variety of physiologic functions including: regulation of heart rate, cardiac contractility, blood pressure, and regulation of smooth muscle tone in several tissues. Beta receptor agonists are used for the treatment of asthma, premature labor and acute heart failure. Beta receptor antagonists are used for the treatment of hypertension and chronic heart failure.
The beta 1 ARGDM will provide an experimental animal model to identify the functions mediated by the beta 1 AR subtype. Furthermore, these mice will be valuable for testing the in vivo selectivity of new drugs for the beta 1 AR subtype.
For more information about Dr. Kobilka's research, click http://www-med3.stanford.edu/frd/frd.lasso?-database=bluebook2.fmp&-layout=profile&-response=profile.lasso&-recid=32971&-search.
Similar Technologies
-
Animal Model of Social Dysfunction S10-332Animal Model of Social Dysfunction
-
Fostm2.1(icre/ERT2)Luo/J mouse line (Jackson Labs Stock no. 030323) - A transgenic mouse that allows permanent genetic access of neurons based on their activity during a drug period S20-227Fostm2.1(icre/ERT2)Luo/J mouse line (Jackson Labs Stock no. 030323) - A transgenic mouse that allows permanent genetic access of neurons based on their activity during a drug period
-
CRISPR/Cas9 Knock-in Mice, Jackson Labs stock number 026816 and stock number 027650, 028239, 027632 S15-174CRISPR/Cas9 Knock-in Mice, Jackson Labs stock number 026816 and stock number 027650, 028239, 027632